Rockwell Medical, Inc. (NASDAQ:RMTI) Short Interest Up 32.6% in September

Rockwell Medical, Inc. (NASDAQ:RMTI - Get Free Report) was the recipient of a large increase in short interest in September. As of September 30th, there was short interest totalling 527,000 shares, an increase of 32.6% from the September 15th total of 397,500 shares. Based on an average daily trading volume, of 488,400 shares, the short-interest ratio is currently 1.1 days. Approximately 1.9% of the shares of the company are sold short.

Hedge Funds Weigh In On Rockwell Medical

Several large investors have recently modified their holdings of RMTI. SkyOak Wealth LLC increased its position in shares of Rockwell Medical by 47.3% during the 1st quarter. SkyOak Wealth LLC now owns 25,110 shares of the company's stock valued at $42,000 after purchasing an additional 8,065 shares during the last quarter. Vanguard Group Inc. grew its position in Rockwell Medical by 4.0% in the 1st quarter. Vanguard Group Inc. now owns 1,118,277 shares of the company's stock valued at $1,856,000 after acquiring an additional 43,302 shares during the last quarter. Renaissance Technologies LLC grew its position in Rockwell Medical by 877.1% in the 2nd quarter. Renaissance Technologies LLC now owns 102,700 shares of the company's stock valued at $181,000 after acquiring an additional 92,189 shares during the last quarter. Finally, Armistice Capital LLC grew its position in Rockwell Medical by 22.5% in the 2nd quarter. Armistice Capital LLC now owns 3,221,640 shares of the company's stock valued at $5,670,000 after acquiring an additional 592,000 shares during the last quarter. Institutional investors own 23.31% of the company's stock.

Rockwell Medical Price Performance

NASDAQ RMTI traded up $0.16 during trading hours on Friday, reaching $3.44. The company's stock had a trading volume of 400,826 shares, compared to its average volume of 294,282. The company has a quick ratio of 1.60, a current ratio of 2.00 and a debt-to-equity ratio of 0.41. Rockwell Medical has a 1 year low of $1.16 and a 1 year high of $4.57. The firm's 50-day moving average price is $3.23 and its 200-day moving average price is $2.26. The company has a market capitalization of $104.29 million, a price-to-earnings ratio of -9.56 and a beta of 1.48.

Rockwell Medical (NASDAQ:RMTI - Get Free Report) last released its quarterly earnings data on Thursday, August 8th. The company reported $0.01 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.04) by $0.05. Rockwell Medical had a negative return on equity of 6.96% and a negative net margin of 5.06%. The business had revenue of $25.83 million for the quarter, compared to the consensus estimate of $23.01 million. During the same quarter in the previous year, the company posted ($0.18) EPS. On average, equities research analysts predict that Rockwell Medical will post -0.03 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the company. StockNews.com raised Rockwell Medical from a "sell" rating to a "hold" rating in a report on Wednesday, June 19th. HC Wainwright reissued a "buy" rating and issued a $9.00 price target on shares of Rockwell Medical in a report on Wednesday, September 11th.

About Rockwell Medical

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.